Search

Your search keyword '"Pollo , B."' showing total 487 results

Search Constraints

Start Over You searched for: Author "Pollo , B." Remove constraint Author: "Pollo , B."
487 results on '"Pollo , B."'

Search Results

1. First Ex-Vivo Validation of a Radioguided Surgery Technique with beta- Radiation

3. Radio-Guided Surgery with β − Radiation: Tests on Ex-Vivo Specimens

6. First ex vivo validation of a radioguided surgery technique with [formula omitted]-radiation.

7. Radio-Guided Surgery with β− Radiation: Tests on Ex-Vivo Specimens

9. Long term follow up in 183 high grade meningioma: A single institutional experience

13. P1359: USING GENE-MODIFIED AUTOLOGOUS STEM CELLS PROGENY TO REEDUCATE THE TUMOR IMMUNE MICROENVIRONMENT OF SOLID TUMORS (TEM-GBM STUDY)

14. IL-4 Gene Transfer for the Treatment of Experimental Gliomas

15. Gene Transfer of Suicide Genes for the Treatment of Malignant Gliomas: Efficacy, Limitations, and Perspectives for a Combined Immunotherapy

18. Molecular and translational advances in meningiomas

19. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life

22. 379TiP TEM-GBM: A phase I-IIa clinical study of genetically modified Tie-2-expressing monocytes in patients with glioblastoma multiforme

29. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management

39. Oncogenic signaling pathways in the Cancer Genome Atlas

41. Advances in multidisciplinary therapy for meningiomas

42. Imaging and diagnostic advances for intracranial meningiomas

43. Abstracts

45. italian consensus and recommendations on diagnosis and treatment of low-grade gliomas an intersociety (siNch/aiNo/siN) document

47. Erratum: The Immune Landscape of Cancer (Immunity (2018) 48(4) (812–830.e14), (S1074761318301213), (10.1016/j.immuni.2018.03.023))

48. The β - radio-guided surgery: Method to estimate the minimum injectable activity from ex-vivo test

50. P05.02 A phase I/IIa dose escalation study evaluating the safety and efficacy of autologous CD34+ enriched hematopoietic progenitor cells genetically modified for human interferon-α2 in patients with GBM and an unmethylated MGMT promoter (TEM-GBM-001)

Catalog

Books, media, physical & digital resources